Physician profile
Neil Roy
NPI 1548418981
$1,745.07
in general payments reported to CMS, 2019-2025
18 companies · $434 in 2025
The $434 reported for 2025 was more than what 92% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $41.97 · 2022: $149 · 2023: $427 · 2024: $551 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,411.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $365.55 | 2024-2025 | Yeztugo |
| Kerecis Limited | $161.83 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Supreme Orthopedic Systems, LLC | $159.59 | 2023 | |
| Ethicon US, LLC | $140.91 | 2025 | Echelon Flex, Harmonic, Stratafix |
| Astellas Pharma US INC | $124.95 | 2022 | |
| Sanara Medtech INC. | $120.81 | 2024 | Celleraterx |
| Smith+Nephew, INC. | $117.63 | 2019-2024 | Pico 14, Pico 7 |
| Idorsia Pharmaceuticals US INC | $105.40 | 2023 | Quviviq |
| Lilly USA, LLC | $93.85 | 2024 | Mounjaro |
| Abbott Laboratories | $89.83 | 2025 | Freestyle Libre 3 |
| Stryker Corporation | $80.96 | 2025 | Pangea, Iconix, Alphavent |
| Allergan, INC. | $41.39 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $33.88 | 2019 | |
| Ucb, INC. | $29.69 | 2019-2020 | |
| Abbvie INC. | $24.54 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $23.53 | 2019 | |
| Portola Pharmaceuticals, LLC | $17.96 | 2019 | |
| Pfizer INC. | $12.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.